Skip to main content
. 2021 Jan 26;21(3):234. doi: 10.3892/ol.2021.12495

Figure 6.

Figure 6.

PUMA is associated with survival in patients with gallbladder carcinoma. Patients in the PUMA high group presented with a longer overall survival time compared with those in the PUMA low group. *P<0.05. PUMA, p53-upregulated modulator of apoptosis.